Dentists in Ione, CA Accepting Medicare
7 Dentists found. Showing 1 - 7
 Dr. Thomas W Eaton, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 15 W. Main St, Ione, CA 95640 Phone: 209-274-2429 Fax: 209-274-0569 |
George Arthur Morris, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 4001 Hwy 104, Ione, CA 95640 Phone: 209-274-4911 |
Dr. Bradley Archibald, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4001 Highway 104, Ione, CA 95640 Phone: 209-274-4911 |
 Dr. Ellen N Ling, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 4001 Hwy 104, Ione, CA 95640 Phone: 209-274-4911 Fax: 209-274-5167 |
Dr. Mark Lyle Muckey, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 201 Waterman Rd, Ione, CA 95640 Phone: 209-274-8245 |
Dr. Edwin Michael Williams, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 4001 Highway 104, Ione, CA 95640 Phone: 209-274-4911 |
Dr. Geoffrey Douglas Webster, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: Mule Creek State Prison,hwy 104, Ione, CA 95640 Phone: 209-274-4911 |
News Archive
Investigators report that cell-permeable NLS peptide shows promise in controlling atherosclerotic disease
Atherosclerosis - sometimes called "hardening of the arteries" - is a leading cause of death and morbidity in Western countries. A cell-permeable peptide containing the NF-ĸB nuclear localization sequence (NLS) shows promise as a potential agent in controlling the development of atherosclerotic disease.
Oncopeptides launches phase II study to determine efficacy of melflufen in treatement of multiple myeloma
Oncopeptides AB, a company working to enhance oncology therapies, today announced that the first patient has been dosed as part of a Phase II study in multiple myeloma patients with its drug candidate melflufen (previously called J1).
New model describes how cultural traumas may drive health disparities
A pair of researchers at the University of California, Riverside, has proposed a new model of "cultural trauma" that describes how traumas such as colonization, hate crimes, and recent anti-immigrant media and policies may drive health disparities in many U.S. cultural groups.
FDA permits marketing of Dexcom G6 integrated continuous glucose monitoring system
The U.S. Food and Drug Administration today permitted marketing of the Dexcom G6 integrated continuous glucose monitoring system for determining blood glucose (sugar) levels in children aged two and older and adults with diabetes.
› Verified 6 days ago